LEWIS, RUSSELL EDWARD
 Distribuzione geografica
Continente #
NA - Nord America 323
EU - Europa 162
AS - Asia 105
SA - Sud America 6
AF - Africa 3
Totale 599
Nazione #
US - Stati Uniti d'America 323
IT - Italia 110
SG - Singapore 58
CN - Cina 21
GB - Regno Unito 17
PL - Polonia 12
HK - Hong Kong 8
TH - Thailandia 7
FI - Finlandia 6
SE - Svezia 6
AE - Emirati Arabi Uniti 5
DE - Germania 4
AR - Argentina 3
PE - Perù 3
FR - Francia 2
GH - Ghana 2
IN - India 2
KW - Kuwait 2
RU - Federazione Russa 2
ES - Italia 1
JP - Giappone 1
LK - Sri Lanka 1
NL - Olanda 1
RO - Romania 1
SC - Seychelles 1
Totale 599
Città #
Fairfield 47
Singapore 42
Padova 28
Ashburn 21
Cambridge 19
Houston 19
Wilmington 15
Seattle 14
Woodbridge 13
Ann Arbor 12
Gdansk 12
Milan 12
Chandler 11
Beijing 9
Hong Kong 8
Kilburn 8
San Diego 8
Mestre 7
Santa Clara 7
Camogli 6
Este 6
Abu Dhabi 5
London 5
Naples 5
Arezzo 4
Bologna 4
Guangzhou 4
Hat Yai 4
Medford 4
Ogden 4
Princeton 4
Romano d'Ezzelino 4
Treviso 4
Bangkok 3
Buenos Aires 3
Greenville 3
Helsinki 3
Lappeenranta 3
Lima 3
Porto San Giorgio 3
Rimini 3
Rome 3
Roxbury 3
Weihai 3
Accra 2
Boardman 2
Des Moines 2
Fie Allo Sciliar 2
Kuwait City 2
Livorno 2
Moscow 2
New York 2
Roseville 2
Turin 2
Verona 2
Amsterdam 1
Atlanta 1
Augusta 1
Battipaglia 1
Bengaluru 1
Bonndorf 1
Bordeaux 1
Cologne 1
Columbus 1
Council Bluffs 1
Frankfurt am Main 1
Hebei 1
Hounslow 1
Los Angeles 1
Mahé 1
Mumbai 1
Nanjing 1
Nugegoda 1
Para 1
Phoenix 1
Sudbury 1
Taunton 1
Tokyo 1
Villafranca di Verona 1
Totale 454
Nome #
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 94
A Prospective Multicentre Study of the Epidemiology and Outcomes of Bloodstream Infection in Cirrhotic Patients 88
Development of a Risk Prediction Model for Carbapenem-Resistant Enterobacteriaceae Infection after Liver Transplantation: A Multinational Cohort Study 44
Epidemiology of Invasive Pulmonary Aspergillosis among Intubated Patients with COVID-19: A Prospective Study 36
Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association 35
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 33
Utility of triazole antifungal therapeutic drug monitoring: Insights from the Society of Infectious Diseases Pharmacists 19
Investigational Antifungal Agents for Invasive Mycoses: A Clinical Perspective 16
Combination antifungal therapy for breakthrough invasive mould disease in patients with haematological malignancies: When management reasoning eclipses evidence-based medicine 16
Infections in the Immunocompromised Host 15
Management of drug–drug interactions of targeted therapies for haematological malignancies and triazole antifungal drugs 15
Breakthrough mucormycosis developing on mucorales-active antifungals portrays a poor prognosis in patients with hematologic cancer 14
Managing uncertainty in antifungal dosing: antibiograms, therapeutic drug monitoring and drug-drug interactions 14
Reply to Day et al 13
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales 13
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 12
Early low-dose computed tomography with pulmonary angiography to improve the early diagnosis of invasive mould disease in patients with haematological malignancies: A pilot study 11
Chimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection? 10
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study 9
Core recommendations for antifungal stewardship: a statement of the mycoses study group education and research consortium 9
Antifungal Prophylaxis in the Era of Targeted Chemotherapy for Acute Myelogenous Leukemia 9
Infectious disease consultation for candidaemia 8
How long do we need to treat an invasive mold disease in hematology patients? factors influencing duration of therapy and future questions 8
Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in patients colonized with Candida spp 8
The lower respiratory tract microbiome of critically ill patients with COVID-19 8
Ceftolozane-tazobactam treatment of hypervirulent multidrug resistant pseudomonas aeruginosa infections in neutropenic patients 7
Quandaries of deciding when to change first-line therapy in invasive pulmonary aspergillosis 7
Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study 7
Successful Treatment of Paecilomyces variotii Pneumonia and Lupus Nephritis With Posaconazole-Cyclophosphamide Co-administration Without Drug Interaction–Induced Toxicity 7
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 7
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 7
Liposomal amphotericin B-the future 6
Chimeric antigen receptor T-cell immunotherapy and need for prophylaxis for invasive mold infections 6
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion 5
Radiology-based diagnosis of fungal pulmonary infections in high-risk hematology patients: are we making progress? 5
Invasive Aspergillosis Due to Aspergillus Section Usti: A Multicenter Retrospective Study 5
Serum bactericidal titres for monitoring antimicrobial therapy: current status and potential role in the management of multidrug-resistant Gram-negative infections 5
Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis 4
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis 4
Role and interpretation of antifungal susceptibility testing for the management of invasive fungal infections 3
Totale 642
Categoria #
all - tutte 6.291
article - articoli 6.196
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 95
Totale 12.582


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202033 0 1 0 1 3 2 2 5 8 5 6 0
2020/202179 2 3 3 2 2 0 1 31 11 6 4 14
2021/202268 2 14 9 0 1 10 6 5 0 5 7 9
2022/2023117 8 3 1 1 4 3 0 2 2 86 2 5
2023/2024275 5 7 42 26 15 4 19 25 36 29 23 44
2024/202548 8 40 0 0 0 0 0 0 0 0 0 0
Totale 642